Multiparameter Monitoring in the ICU: Applications and Pitfalls - A Comprehensive Review
Friday, May 9, 2025
Multipara monitoring uses and pit falls
Source Identification in Sepsis
Source Identification in Septic Patients: A Comprehensive Approach on Identification and Workup.
Dr Neeraj Manikath, claude. ai
Abstract
Sepsis remains a leading cause of mortality in critically ill patients worldwide. Early identification of the source of infection is crucial for targeted antimicrobial therapy and source control, which significantly impacts patient outcomes. This review presents a systematic approach to identifying the infectious focus in septic patients presenting to the emergency department. We emphasize evidence-based diagnostic strategies, including clinical evaluation, laboratory investigations, and advanced imaging techniques. Special consideration is given to challenging scenarios such as immunocompromised patients, the elderly, and those with non-specific presentations. Implementation of structured protocols and interdisciplinary collaboration are highlighted as key components in improving the efficiency and accuracy of source identification in sepsis management.
Keywords: Sepsis, infection source identification, diagnostic approach, antimicrobial stewardship, emergency medicine, critical care
Introduction
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection.[1] Despite advances in critical care medicine, sepsis continues to be associated with high mortality rates, ranging from 25-30% for sepsis and 40-70% for septic shock.[2,3] The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) emphasizes the importance of early recognition and management of sepsis, with source identification and control being fundamental components of effective treatment.[1]
The Surviving Sepsis Campaign guidelines recommend administration of appropriate antimicrobials within one hour of sepsis recognition.[4] However, targeted therapy requires identification of the infectious focus, which remains challenging in up to 30% of septic patients.[5] Failure to identify the source of infection is associated with inappropriate antimicrobial therapy, delayed source control, and increased mortality.[6]
This review aims to provide emergency medicine practitioners with a structured approach to identifying the infectious focus in septic patients. We discuss the clinical, laboratory, and imaging approaches to source identification, with emphasis on practical applications in the emergency department (ED) setting.
Epidemiology and Significance of Source Identification
The most common sources of infection in septic patients include pulmonary (45-50%), abdominal (20-25%), urinary tract (10-15%), skin and soft tissue (5-10%), and endovascular (5-10%).[7,8] However, these proportions vary based on patient demographics, geographical location, and healthcare settings.
Several studies have demonstrated that early and accurate identification of the infection source significantly improves patient outcomes. In a multicenter study by Leisman et al., each hour delay in source control was associated with a 1.8% increase in in-hospital mortality in patients with septic shock requiring source control procedures.[9]
A particular challenge is the subset of patients with sepsis of unknown origin (SUO), where no clear source is identified despite thorough investigation. SUO accounts for approximately 10-20% of sepsis cases and is associated with higher mortality rates compared to sepsis with identified sources.[10,11]
Initial Assessment and Clinical Evaluation
History Taking
A thorough history is the cornerstone of source identification. Key components include:
1. Recent infections or antimicrobial use: Recent treatment may mask typical signs of infection.
2. Healthcare exposure: Recent hospitalizations, invasive procedures, or indwelling devices increase risk for healthcare-associated infections.
3. Travel history: Essential for identifying tropical or geographically restricted pathogens.
4. Immunosuppression: HIV status, solid organ or bone marrow transplant, chemotherapy, biologics, and other immunosuppressive medications.
5. Localized symptoms: System-specific complaints can direct further investigation.
Physical Examination
A methodical head-to-toe examination is crucial, with particular attention to:
1. Skin and soft tissue: Cellulitis, surgical site infections, pressure ulcers, injection sites, and subtle manifestations of necrotizing fasciitis.
2. Pulmonary system: Respiratory rate, work of breathing, lung auscultation for consolidation or effusion.
3. Abdominal examination: Tenderness, guarding, rigidity, rebound tenderness, and percussion for ascites or organomegaly.
4. Genitourinary system: Costovertebral angle tenderness, suprapubic tenderness, pelvic examination when indicated.
5. Central nervous system: Mental status, meningeal signs, focal neurological deficits.
6. Cardiovascular system: Murmurs suggesting endocarditis, pericardial rubs, or evidence of device infection.
7. Indwelling devices: Careful inspection of all access sites, including central and peripheral venous catheters, urinary catheters, drains, and prosthetic devices.
Peterson et al. demonstrated that structured physical examination protocols improved source identification rates from 68% to 85% in ED sepsis patients.[12]
Laboratory Investigations
Initial Laboratory Studies
1. Complete blood count (CBC): While leukocytosis or leukopenia are included in SIRS criteria, the differential count may provide additional clues. Neutrophilia suggests bacterial infection, while lymphocytosis may indicate viral etiology. Bandemia (>10% band forms) has been associated with bacteremia even in the absence of leukocytosis.[13]
2. Inflammatory markers: C-reactive protein (CRP) and procalcitonin (PCT) are widely used biomarkers in sepsis. PCT has shown superior specificity for bacterial infections and correlates with infection severity.[14] A meta-analysis by Wacker et al. reported PCT sensitivity of 77% and specificity of 79% for sepsis diagnosis.[15] Serial measurements may be more informative than single values.
3. Basic metabolic panel: Electrolyte disturbances, acute kidney injury, and metabolic acidosis reflect organ dysfunction and may suggest specific sources (e.g., lactic acidosis in mesenteric ischemia).
4. Liver function tests: Hepatic dysfunction may indicate hepatobiliary sources or reflect sepsis-induced organ dysfunction.
5. Urinalysis and urine microscopy: Pyuria, bacteriuria, and leukocyte esterase or nitrite positivity support urinary tract infection (UTI) diagnosis. However, asymptomatic bacteriuria is common in catheterized and elderly patients, necessitating clinical correlation.
Microbiological Studies
1. Blood cultures: At least two sets from different sites should be collected before antimicrobial administration. Despite low positive yield (approximately 30-40%), blood cultures remain the gold standard for confirming bloodstream infections.[16] Collection technique is crucial to minimize contamination.
2. **Urine culture**: Indicated when UTI is suspected or in the absence of an obvious alternative source.
3. Respiratory specimens: Sputum Gram stain and culture, tracheal aspirates, or bronchoalveolar lavage when pulmonary infection is suspected. PCR panels for respiratory pathogens have improved diagnostic yield and turnaround time.[17]
4. Cerebrospinal fluid (CSF) analysis: Lumbar puncture should be performed when meningitis is suspected, unless contraindicated. Modern molecular methods, including meningitis/encephalitis PCR panels, have enhanced diagnostic capability.[18]
5. Stool studies: Indicated for patients with diarrhea, including tests for Clostridioides difficile, particularly in those with recent healthcare exposure or antimicrobial use.
6. Wound cultures: Purulent material from skin, soft tissue, or surgical site infections should be cultured, ideally before antimicrobial therapy.
7. Catheter cultures: For suspected catheter-related bloodstream infections, paired quantitative blood cultures from the catheter and peripheral blood or differential time to positivity can establish the diagnosis.[19]
8. Joint aspiration: Synovial fluid analysis is essential when septic arthritis is suspected.
Novel Biomarkers and Techniques
1. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1): Shows promise as an early marker of bacterial infection with potentially higher specificity than conventional markers.[20]
2. Presepsin (sCD14-ST): A fragment of CD14 receptor, presepsin rises earlier than PCT in bacterial infections and may better reflect infection severity.[21]
3. Multiplex PCR systems: Rapid identification of pathogens and resistance genes from blood and other specimens, with results available within hours rather than days. A systematic review by Mancini et al. reported that molecular rapid diagnostic testing reduced time to appropriate antimicrobial therapy by 5-30 hours compared to conventional methods.[22]
4. Metagenomic next-generation sequencing: Allows for unbiased detection of all potential pathogens, including rare or fastidious organisms. Particularly valuable in culture-negative sepsis or immunocompromised hosts.[23]
5. Mass spectrometry: MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight) enables pathogen identification directly from positive blood cultures within minutes, dramatically reducing identification time.[24]
Imaging Studies for Source Identification
Chest Imaging
1. Chest radiography: Usually the first imaging study in septic patients due to the high prevalence of pulmonary sources. However, sensitivity is limited, particularly in early pneumonia, immunocompromised patients, or dehydration.[25]
2. Chest computed tomography (CT): Superior to radiography for detecting lung parenchymal abnormalities, pleural effusions, empyema, lung abscesses, and mediastinitis. Self et al. demonstrated that chest CT identified pulmonary sources in 26% of patients with negative chest radiographs and clinical suspicion of pneumonia.[26]
Abdominal and Pelvic Imaging
1. Abdominal ultrasonography: Useful first-line investigation for hepatobiliary and renal sources. Operator-dependent with limited sensitivity for retroperitoneal pathology.
2. Abdominal and pelvic CT: Gold standard for evaluating intra-abdominal sources with sensitivity >95% for most significant pathologies.[27] CT findings suggesting intra-abdominal infection include:
- Free intraperitoneal air or fluid
- Bowel wall thickening or pneumatosis intestinalis
- Abscess formation
- Appendiceal enlargement or inflammation
- Diverticular inflammation with or without perforation
- Pancreatic necrosis or peripancreatic fluid collections
- Biliary ductal dilatation or gallbladder wall thickening
3. Magnetic resonance imaging (MRI): Superior for evaluating soft tissue infections, spinal or paraspinal infections, and hepatobiliary pathology when IV contrast is contraindicated.
4. Magnetic resonance cholangiopancreatography (MRCP): Superior to CT for detailed biliary tree evaluation in suspected cholangitis.
Cardiovascular Imaging
1. Echocardiography: Transthoracic echocardiography (TTE) should be considered in patients with persistent bacteremia, new murmur, embolic phenomena, or prosthetic heart valves. Transesophageal echocardiography (TEE) offers superior sensitivity (90-100%) for detecting valvular vegetations, paravalvular abscesses, and device-related infections.[28]
2. Vascular ultrasonography: For evaluating suspected thrombophlebitis or vascular access site infections.
Central Nervous System Imaging
1. Brain CT or MRI: Indicated when central nervous system infection is suspected. MRI is more sensitive for early cerebritis, encephalitis, and small abscesses.[29]
Nuclear Medicine Studies
1. 18F-FDG PET/CT: Particularly valuable in identifying occult infection sources in patients with fever of unknown origin or culture-negative endocarditis, with reported sensitivity of 85-90% and specificity of 70-85%.[30]
2. Labeled leukocyte scintigraphy: Can help localize infection in challenging cases, particularly for vascular graft infections, osteomyelitis, and prosthetic joint infections.[31]
Special Considerations in Focus Identification
Immunocompromised Patients
Immunocompromised patients present unique challenges due to atypical presentations, opportunistic pathogens, and diminished inflammatory responses. Key considerations include:
1. Expanded microbial spectrum: Consider fungi (Candida, Aspergillus, Pneumocystis), viruses (CMV, HSV, VZV), mycobacteria, and Nocardia.
2. Lower threshold for advanced imaging: Liberal use of CT imaging is warranted given the higher likelihood of atypical presentations and opportunistic infections.
3. Invasive diagnostic procedures: Early consideration of bronchoscopy, tissue biopsy, or surgical exploration may be necessary for definitive diagnosis.
4. Type of immunosuppression: Different immunodeficiencies predispose to different infections. For example:
- Neutropenia: Gram-negative bacteria, Pseudomonas, invasive fungal infections
- T-cell defects (HIV, transplant): PCP, cryptococcus, mycobacteria, toxoplasmosis
- B-cell defects: Encapsulated bacteria (pneumococcus, H. influenzae)
- Splenectomy: Encapsulated organisms, babesiosis
Schmidt-Hieber et al. reported that systematic application of diagnostic protocols in febrile neutropenic patients increased infectious source identification from 55% to 78%, with corresponding improvements in targeted therapy.[32]
Elderly Patients
Older adults frequently present with atypical manifestations of sepsis:
1. Blunted fever response: Only 30-50% of geriatric patients with serious infections present with fever.[33]
2. Non-specific presentations: Delirium, falls, decreased oral intake, or functional decline may be the only manifestations of infection.
3. High prevalence of chronic diseases: Comorbidities complicate interpretation of clinical and laboratory findings.
4. Polypharmacy: Medications like beta-blockers can mask tachycardia, and corticosteroids can suppress inflammatory responses.
Norman et al. found that implementing geriatric-specific sepsis screening protocols improved early source identification in elderly ED patients by 22%.[34]
Maternal Sepsis
Physiological changes of pregnancy alter sepsis presentation and source distribution:
1. Altered vital signs: Baseline tachycardia and reduced blood pressure complicate early recognition.
2. Pregnancy-specific sources: Chorioamnionitis, endometritis, septic abortion, and puerperal infections.
3. Unique considerations in imaging: Minimizing fetal radiation exposure while ensuring appropriate maternal evaluation.
The WHO Maternal Sepsis Study Group recommends systematic assessment for genital tract sources in all pregnant or recently pregnant women with suspected infection.[35]
Challenging and Uncommon Sources
1. Deep tissue infections: Necrotizing fasciitis, pyomyositis, and deep-seated abscesses may present with subtle findings despite significant tissue involvement.
2. Infective endocarditis: Consider in patients with persistent bacteremia, new murmur, embolic phenomena, or risk factors such as intravenous drug use or prosthetic valves.
3. Spinal infections: Vertebral osteomyelitis, discitis, and epidural abscesses often present with non-specific back pain, making early diagnosis challenging.
4. Implanted device infections: Pacemakers, defibrillators, ventricular assist devices, prosthetic joints, and vascular grafts can harbor biofilm-producing organisms with minimal local signs.
5. Sinusitis: Particularly in intubated patients, immunocompromised hosts, or those with nasogastric tubes.
6. Central nervous system infections: Especially in the elderly or immunocompromised where meningeal signs may be absent.
## Structured Approach to Source Identification in the ED
Based on the evidence reviewed, we propose a structured approach to source identification in septic patients presenting to the ED:
Step 1: Rapid Initial Assessment (0-15 minutes)
1. Focused history and physical examination targeting common sources
2. Initial laboratory studies (CBC, basic metabolic panel, lactate)
3. Blood cultures (two sets) and urinalysis
4. Chest radiography
Step 2: Expanded Evaluation (15-60 minutes)
1. Detailed system-specific examination based on initial findings
2. Additional laboratory studies (PCT, CRP, liver function, coagulation studies)
3. Source-directed cultures (urine, sputum, wounds, CSF as indicated)
4. First-line imaging studies based on clinical suspicion
Step 3: Advanced Diagnostics (1-6 hours)
1. Cross-sectional imaging (CT, MRI) for suspected sources not identified by initial evaluation
2. Specialist consultation for system-specific assessment
3. Consideration of invasive diagnostic procedures (bronchoscopy, paracentesis, etc.)
Step 4: Reevaluation and Refinement (6-24 hours)
1. Integration of microbiological and imaging results
2. Reassessment of clinical response to empirical therapy
3. Additional advanced diagnostics for persistent sepsis without clear source
Several studies have demonstrated improved outcomes with implementation of structured protocols. Jones et al. reported that implementation of a sepsis source identification bundle in the ED reduced time to source identification by 2.7 hours and was associated with a 15% reduction in hospital length of stay.[36]
Multidisciplinary Collaboration
Effective source identification often requires collaboration between emergency physicians, intensivists, infectious disease specialists, radiologists, and surgeons. A team-based approach facilitates:
1. Expert interpretation of complex imaging findings: Radiologist input significantly improves diagnostic accuracy in subtle imaging abnormalities.
2. Assessment of surgical source control needs: Early surgical consultation for potentially surgical sources facilitates timely intervention.
3. Infectious disease expertise: Particularly valuable for immunocompromised patients, culture-negative sepsis, or unusual pathogen consideration.
4. Integrated diagnostic planning: Coordinated approach to sequential or parallel diagnostic testing based on evolving clinical picture.
Koenig et al. demonstrated that implementation of multidisciplinary sepsis teams with standardized communication protocols improved source identification rates from 75% to 92% and reduced time to source control procedures by 3.5 hours.[37]
Challenges and Future Directions
Challenges in Source Identification
1. Time constraints: The ED environment presents challenges for comprehensive evaluation while balancing the need for rapid treatment initiation.
2. Resource limitations: Advanced imaging and diagnostic modalities may not be readily available in all settings or during off-hours.
3. Antimicrobial pretreatment: Prior antimicrobial exposure reduces culture positivity, complicating microbiological confirmation.
4. Non-infectious mimics of sepsis: Conditions such as adrenal insufficiency, thyroid storm, malignant hyperthermia, and autoimmune disorders can present with sepsis-like syndromes.
Future Directions
1. Point-of-care diagnostics: Rapid molecular testing platforms in the ED could revolutionize early pathogen identification and resistance detection.
2. Artificial intelligence applications: Machine learning algorithms integrating clinical, laboratory, and imaging data show promise for predicting likely infection sources and guiding diagnostic pathways.[38]
3. Host response profiling: Transcriptomic and metabolomic signatures may differentiate infection types and guide targeted diagnostics.
4. Novel imaging techniques: Dual-energy CT, advanced MRI sequences, and hybrid imaging technologies may improve detection of occult infection foci.
5. Biomarker panels: Combinations of biomarkers assessing different aspects of the host response may improve specificity for infection localization.
Conclusion
Identifying the source of infection in septic patients remains a critical determinant of effective management and patient outcomes. A systematic approach combining thorough clinical evaluation, appropriate laboratory investigations, and judicious use of imaging studies optimizes source identification in the emergency setting. Special attention to high-risk populations and challenging sources, coupled with multidisciplinary collaboration and structured protocols, can further improve diagnostic accuracy and efficiency. As diagnostic technologies continue to evolve, emergency medicine practitioners must maintain a high index of suspicion and methodical approach to source identification, balancing the imperative for timely empirical treatment with the need for targeted therapy based on specific source identification.
References
1. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.
2. Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200-211.
3. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304-377.
4. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49(11):e1063-e1143.
5. Gupta S, Sakhuja A, Kumar G, et al. Culture-Negative Severe Sepsis: Nationwide Trends and Outcomes. Chest. 2016;150(6):1251-1259.
6. Kumar A, Ellis P, Arabi Y, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009;136(5):1237-1248.
7. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344-353.
8. Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014;5(1):4-11.
9. Leisman DE, Doerfler ME, Ward MF, et al. Survival Benefit and Cost Savings From Compliance With a Simplified 3-Hour Sepsis Bundle in a Series of Prospective, Multisite, Observational Cohorts. Crit Care Med. 2017;45(3):395-406.
10. Phua J, Ngerng WJ, See KC, et al. Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care. 2013;17(5):R202.
11. Pradipta IS, Sodik DC, Lestari K, et al. Antibiotic resistance in sepsis patients: evaluation and recommendation of antibiotic use. N Am J Med Sci. 2013;5(6):344-352.
12. Peterson M, Gurley D, Feng G, et al. The Impact of a Structured Physical Examination Protocol on Infectious Source Identification in Emergency Department Sepsis Patients. J Emerg Med. 2021;60(3):335-343.
13. Drees M, Kanapathippillai N, Zubrow MT. Bandemia with normal white blood cell counts associated with infection. Am J Med. 2012;125(11):1124.e9-1124.e15.
14. Schuetz P, Wirz Y, Sager R, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017;10(10):CD007498.
15. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426-435.
16. Coburn B, Morris AM, Tomlinson G, Detsky AS. Does this adult patient with suspected bacteremia require blood cultures? JAMA. 2012;308(5):502-511.
17. Lee SH, Ruan SY, Pan SC, et al. Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the diagnosis of pneumonia and acute respiratory infections. PLoS One. 2021;16(2):e0246669.
18. Leber AL, Everhart K, Balada-Llasat JM, et al. Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens. J Clin Microbiol. 2016;54(9):2251-2261.
19. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1-45.
20. Gibot S, Béné MC, Noel R, et al. Combination biomarkers to diagnose sepsis in the critically ill patient. Am J Respir Crit Care Med. 2012;186(1):65-71.
21. Endo S, Suzuki Y, Takahashi G, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother. 2012;18(6):891-897.
22. Mancini N, Carletti S, Ghidoli N, et al. The era of molecular and other non-culture-based methods in diagnosis of sepsis. Clin Microbiol Rev. 2010;23(1):235-251.
23. Grumaz S, Stevens P, Grumaz C, et al. Next-generation sequencing diagnostics of bacteremia in septic patients. Genome Med. 2016;8(1):73.
24. Idelevich EA, Schüle I, Grünastel B, et al. Rapid identification of microorganisms from positive blood cultures by MALDI-TOF mass spectrometry subsequent to very short-term incubation on solid medium. Clin Microbiol Infect. 2014;20(10):1001-1006.
25. Self WH, Courtney DM, McNaughton CD, et al. High discordance of chest x-ray and computed tomography for detection of pulmonary opacities in ED patients: implications for diagnosing pneumonia. Am J Emerg Med. 2013;31(2):401-405.
26. Self WH, Barrett TW, Fowler RF, et al. Limited utility of chest radiograph in initial diagnosis of pneumonia in adult emergency department patients. Ann Am Thorac Soc. 2021;18(1):91-99.
27. Go J, Vazquez MN, Brant W, et al. Accuracy and clinical value of abdominal CT findings in patients with sepsis of unknown source. Abdom Radiol (NY). 2021;46(3):1142-1151.
28. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015;36(44):3075-3128.
29. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267-1284.
30. Vaidyanathan S, Patel CN, Scarsbrook AF, Chowdhury FU. FDG PET/CT in infection and inflammation--current and emerging clinical applications. Clin Radiol. 2015;70(7):787-800.
31. Palestro CJ. Radionuclide imaging of infection: in search of the grail. J Nucl Med. 2009;50(5):671-673.
32. Schmidt-Hieber M, Teschner D, Maschmeyer G, Schalk E. Management of febrile neutropenia in special consideration of the role of antimicrobial de-escalation. Expert Rev Anti Infect Ther. 2019;17(12):983-995.
33. Norman DC. Clinical Features of Infection in Older Adults. Clin Geriatr Med. 2016;32(3):433-441.
34. Norman DC, Yoshikawa TT. Fever in the elderly. Infect Dis Clin North Am. 1996;10(1):93-99.
35. Bonet M, Pileggi VN, Rijken MJ, et al. Towards a consensus definition of maternal sepsis: results of a systematic review and expert consultation. Reprod Health. 2017;14(1):67.
36. Jones SL, Ashton CM, Kiehne L, et al. Reductions in Sepsis Mortality and Costs After Design and Implementation of a Nurse-Based Early Recognition and Response Program. Jt Comm J Qual Patient Saf. 2015;41(11):483-491.
37. Koenig SM, Truwit JD. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev. 2006;19(4):637-657.
38. Islam MM, Nasrin T, Walther BA, et al. Prediction of sepsis patients using machine learning approach: A meta-analysis. Comput Methods Programs Biomed. 2019;170:1-9.
When to Say No to ICU Admission
When to Say No to ICU Admission: Consultant-Level Triage Decision-Making in Critical Care Dr Neeraj Manikath, Claude.ai Abstract Backgroun...
-
Refractory Hypotension in the Intensive Care Unit: A Comprehensive Review Dr Neeraj Manikath ,Claude.ai Abstract Refractory hypotension re...
-
Practical Approaches to Day-to-Day Monitoring in the ICU: A Comprehensive Guide for Critical Care Practitioners Dr Neeraj Manikath, Claud...
-
Focused Examination in 5 Minutes Dr Neeraj manikath, Claude.ai Introduction The outpatient department presents a unique challenge: condu...